Could gestational diabetes mellitus be managed through dietary bioactive compounds? Current knowledge and future perspectives

British Journal of Nutrition

Volumn 115, Issue 7, 2016, Pages 1129-1144

  Santangelo, Carmela ^a   Zicari, Alessandra ^b   Mandosi, Elisabetta ^b   Scazzocchio, Beatrice ^a   Mari, Emanuela ^b   Morano, Susanna ^b   Masella, Roberta ^a  

^a ISTITUTO SUPERIORE DI SANITÀ   (Italy)

^b SAPIENZA UNIVERSITY OF ROME   (Italy)

Author keywords

Adipokines; Dietary polyphenols; Gestational diabetes mellitus; Mediterranean diet; MicroRNA; Molecular mechanisms; PUFA

Indexed keywords

ADIPOCYTOKINE; FLAVONOID; INSULIN; MICRORNA; POLYPHENOL; POLYUNSATURATED FATTY ACID; GLUCOSE BLOOD LEVEL; UNSATURATED FATTY ACID;

ARTICLE; BIOMICS; DIET THERAPY; DISEASE COURSE; GLUCOSE HOMEOSTASIS; HUMAN; HYPERGLYCEMIA; IN VITRO STUDY; INSULIN RESISTANCE; NONHUMAN; PREGNANCY DIABETES MELLITUS; ANIMAL; DIABETES, GESTATIONAL; DIET; DRUG EFFECTS; FEMALE; FRUIT; GLUCOSE BLOOD LEVEL; HOMEOSTASIS; METABOLISM; PHYSIOLOGY; PREGNANCY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; VEGETABLE;

ADIPOKINES; ANIMALS; BLOOD GLUCOSE; DIABETES, GESTATIONAL; DIET; FATTY ACIDS, UNSATURATED; FEMALE; FLAVONOIDS; FRUIT; HOMEOSTASIS; HUMANS; INSULIN; INSULIN RESISTANCE; MICRORNAS; POLYPHENOLS; PREGNANCY; SIGNAL TRANSDUCTION; TREATMENT OUTCOME; VEGETABLES;

EID: 84960813177     PISSN: 00071145     EISSN: 14752662     Source Type: Journal    
DOI: 10.1017/S0007114516000222     Document Type: Article

References (200)

1. Chen P, Wang S, Ji J, et al. (2015) Risk factors and management of gestational diabetes. Cell Biochem Biophys 71, 689-694.
2. Yuen L & Wong VW (2015) Gestational diabetes mellitus: challenges for different ethnic groups. World J Diabetes 6, 1024-1032.
3. Bao W, Yeung E, Tobias DK, et al. (2015) Long-term risk of type 2 diabetes mellitus in relation to BMI and weight change among women with a history of gestational diabetes mellitus: a prospective cohort study. Diabetologia 58, 1212-1219.
4. Harris DL, Weston PJ & Harding JE (2012) Incidence of neonatal hypoglycemia in babies identified as at risk. J Pediatr 161, 787-791.
5. Yessoufou A & Moutairou K (2011) Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of 'metabolic memory'. Exp Diabetes Res 2011, 218598.
6. Benhalima K, Mathieu C, Damm P, et al. (2015) A proposal for the use of uniform diagnostic criteria for gestational diabetes in Europe: an opinion paper by the European Board & College of Obstetrics and Gynaecology (EBCOG). Diabetologia 58, 1422-1429.
7. Agarwal MM (2015) Gestational diabetes mellitus: an update on the current international diagnostic criteria. World J Diabetes 6, 782-791.
8. Sacks DA, Hadden DR, Maresh M, et al. (2012) Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study. Diabetes Care 35, 526-528.
9. Santangelo C, Vari R, Scazzocchio B, et al. (2014) Management of reproduction and pregnancy complications in maternal obesity: which role for dietary polyphenols? Biofactors 40, 79-102.
10. Georgoulis M, Kontogianni MD & Yiannakouris N (2014) Mediterranean diet and diabetes: prevention and treatment. Nutrients 6, 1406-1423.
11. Sofi F, Macchi C, Abbate R, et al. (2014) Mediterranean diet and health status: an updated meta-analysis and a proposal for a literature-based adherence score. Public Health Nutr 17, 2769-2782.
12. Capurso C, Massaro M, Scoditti E, et al. (2014) Vascular effects of the Mediterranean diet part I: anti-hypertensive and anti-thrombotic effects. Vascul Pharmacol 63, 118-126.
13. Esposito K, Maiorino MI, Bellastella G, et al. (2015) A journey into a Mediterranean diet and type 2 diabetes: a systematic review with meta-analyses. BMJ Open 5, e008222.
14. Bonaccio M, Di Castelnuovo A, Costanzo S, et al. (2015) Adherence to the traditional Mediterranean diet and mortality in subjects with diabetes. Prospective results from the MOLI-SANI study. Eur J Prev Cardiol (epublication ahead of print version 3 February 2015).
15. Koloverou E, Panagiotakos DB, Pitsavos C, et al. (2016) Adherence to Mediterranean diet and 10-year incidence (2002-2012) of diabetes: correlations with inflammatory and oxidative stress biomarkers in the ATTICA cohort study. Diabetes Metab Res Rev 32, 73-81.
16. Yang J, Farioli A, Korre M, et al. (2014) Modified Mediterranean diet score and cardiovascular risk in a North American working population. PLOS ONE 9, e87539.
17. Steffen LM, Van Horn L, Daviglus ML, et al. (2014) Amodified Mediterranean diet score is associated with a lower risk of incident metabolic syndrome over 25 years among young adults: the CARDIA (Coronary Artery Risk Development in Young Adults) study. Br J Nutr 112, 1654-1661.
18. Hoscan Y, Yigit F & Muderrisoglu H (2015) Adherence to Mediterranean diet and its relation with cardiovascular diseases in Turkish population. Int J Clin Exp Med 8, 2860-2866.
19. Grosso G, Stepaniak U, Micek A, et al. (2015) A Mediterranean-type diet is associated with better metabolic profile in urban Polish adults: results from the HAPIEE study. Metabolism 64, 738-746.
20. Asemi Z, Samimi M, Tabassi Z, et al. (2014) The effect of DASH diet on pregnancy outcomes in gestational diabetes: a randomized controlled clinical trial. Eur J Clin Nutr 68, 490-495.
21. Tobias DK, Zhang C, Chavarro J, et al. (2012) Prepregnancy adherence to dietary patterns and lower risk of gestational diabetes mellitus. Am J Clin Nutr 96, 289-295.
22. Karamanos B, Thanopoulou A, Anastasiou E, et al. (2014) Relation of the Mediterranean diet with the incidence of gestational diabetes. Eur J Clin Nutr 68, 8-13.
23. Salas-Salvado J, Martinez-Gonzalez MA, Bullo M, et al. (2011) The role of diet in the prevention of type 2 diabetes. Nutr Metab Cardiovasc Dis 21, Suppl. 2, B32-B48.
24. Samimi M, Jamilian M, Asemi Z, et al. (2015) Effects of omega-3 fatty acid supplementation on insulin metabolism and lipid profiles in gestational diabetes: randomized, double-blind, placebo-controlled trial. Clin Nutr 34, 388-393.
25. Wang H, Jiang H, Yang L, et al. (2015) Impacts of dietary fat changes on pregnant women with gestational diabetes mellitus: a randomized controlled study. Asia Pac J Clin Nutr 24, 58-64.
26. Mirmiran P, Bahadoran Z & Azizi F (2014) Functional foodsbased diet as a novel dietary approach for management of type 2 diabetes and its complications: a review. World J Diabetes 5, 267-281.
27. Xiao JB & Hogger P (2015) Dietary polyphenols and type 2 diabetes: current insights and future perspectives. Curr Med Chem 22, 23-38.
28. Bahadoran Z, Mirmiran P & Azizi F (2013) Dietary polyphenols as potential nutraceuticals in management of diabetes: a review. J Diabetes Metab Disord 12, 43.
29. Oh YS & Jun HS (2014) Role of bioactive food components in diabetes prevention: effects on beta-cell function and preservation. Nutr Metab Insights 7, 51-59.
30. Saunders AV, Davis BC & Garg ML (2013) Omega-3 polyunsaturated fatty acids and vegetarian diets. Med J Aust 199, S22-S26.
31. Trichopoulou A, Bamia C & Trichopoulos D (2009) Anatomy of health effects of Mediterranean diet: Greek EPIC prospective cohort study. BMJ 338, b2337.
32. Bravo L (1998) Polyphenols: chemistry, dietary sources, metabolism, and nutritional significance. Nutr Rev 56, 317-333.
33. Scalbert A, Manach C, Morand C, et al. (2005) Dietary polyphenols and the prevention of diseases. Crit Rev Food Sci Nutr 45, 287-306.
34. Neveu V, Perez-Jimenez J, Vos F, et al. (2010) Phenol-Explorer: an online comprehensive database on polyphenol contents in foods. Database (Oxford) 2010, bap024.
35. Manach C, Scalbert A, Morand C, et al. (2004) Polyphenols: food sources and bioavailability. Am J Clin Nutr 79, 727-747.
36. Perez-Jimenez J, Fezeu L, Touvier M, et al. (2011) Dietary intake of 337 polyphenols in French adults. Am J Clin Nutr 93, 1220-1228.
37. Tsao R (2010) Chemistry and biochemistry of dietary polyphenols. Nutrients 2, 1231-1246.
38. Landete JM (2012) Updated knowledge about polyphenols: functions, bioavailability, metabolism, and health. Cri Rev Food Sci Nutr 52, 936-948.
39. Del Rio D, Costa LG, Lean ME, et al. (2010) Polyphenols and health: what compounds are involved? Nutr Metab Cardiovasc Dis 20, 1-6.
40. Lancon A, Michaille JJ & Latruffe N (2013) Effects of dietary phytophenols on the expression of microRNAs involved in mammalian cell homeostasis. J Sci Food Agric 93, 3155-3164.
41. Santangelo C, Vari R, Scazzocchio B, et al. (2007) Polyphenols, intracellular signalling and inflammation. Ann Ist Super Sanita 43, 394-405.
42. Sebastian RS, Wilkinson Enns C, Goldman JD, et al. (2015) A new database facilitates characterization of flavonoid intake, sources, and positive associations with diet quality among US adults. J Nutr 145, 1239-1248.
43. Zamora-Ros R, Forouhi NG, Sharp SJ, et al. (2014) Dietary intakes of individual flavanols and flavonols are inversely associated with incident type 2 diabetes in European populations. J Nutr 144, 335-343.
44. D'Archivio M, Filesi C, Vari R, et al. (2010) Bioavailability of the polyphenols: status and controversies. Int J Mol Sci 11, 1321-1342.
45. Fraga CG, Galleano M, Verstraeten SV, et al. (2010) Basic biochemical mechanisms behind the health benefits of polyphenols. Mol Aspects Med 31, 435-445.
46. Monteagudo C, Mariscal-Arcas M, Rivas A, et al. (2015) Proposal of a Mediterranean Diet Serving Score. PLOS ONE 10, e0128594.
47. Gonzalez S, Fernandez M, Cuervo A, et al. (2014) Dietary intake of polyphenols and major food sources in an institutionalised elderly population. J Hum Nutr Diet 27, 176-183.
48. Murphy MM, Barraj LM, Spungen JH, et al. (2014) Global assessment of select phytonutrient intakes by level of fruit and vegetable consumption. Br J Nutr 112, 1004-1018.
49. United States Department of Agriculture (USDA) Agricultural Research Service (ARS) (2012) Nutrient Data Laboratory USDA National Nutrient Database for Standard reference. http:// www. nal. usda. gov/fnic/foodcomp/search
50. Wang J, Tang L & Wang JS (2015) Biomarkers of dietary polyphenols in cancer studies: current evidence and beyond. Oxid Med Cell Longev 2015, 732302.
51. Edmands WM, Ferrari P, Rothwell JA, et al. (2015) Polyphenol metabolome in human urine and its association with intake of polyphenol-rich foods across European countries. Am J Clin Nutr 102, 905-913.
52. Scalbert A, Brennan L, Manach C, et al. (2014) The food metabolome: a window over dietary exposure. Am J Clin Nutr 99, 1286-1308.
53. Sonagra AD, Biradar SM, K D, et al. (2014) Normal pregnancy-a state of insulin resistance. J Clin Diagn Res 8, CC01-CC03.
54. Catalano PM, Huston L, Amini SB, et al. (1999) Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus. Am J Obstet Gynecol 180, 903-916.
55. Harlev A & Wiznitzer A (2010) New insights on glucose pathophysiology in gestational diabetes and insulin resistance. Curr Diab Rep 10, 242-247.
56. Catalano PM (2014) Trying to understand gestational diabetes. Diabet Med 31, 273-281.
57. Friedman JE, Ishizuka T, Shao J, et al. (1999) Impaired glucose transport and insulin receptor tyrosine phosphorylation in skeletal muscle from obese women with gestational diabetes. Diabetes 48, 1807-1814.
58. Tersigni C, Di Nicuolo F, D'Ippolito S, et al. (2011) Adipokines: new emerging roles in fertility and reproduction. Obstet Gynecol Surv 66, 47-63.
59. Li N, Liu E, Guo J, et al. (2013) Maternal prepregnancy body mass index and gestational weight gain on pregnancy outcomes. PLOS ONE 8, e82310.
60. Lappas M (2014) Activation of inflammasomes in adipose tissue of women with gestational diabetes. Mol Cell Endocrinol 382, 74-83.
61. Krutzfeldt J & Stoffel M (2006) MicroRNAs: a new class of regulatory genes affecting metabolism. Cell Metab 4, 9-12.
62. Mao Y, Mohan R, Zhang S, et al. (2013) MicroRNAs as pharmacological targets in diabetes. Pharmacol Res 75, 37-47.
63. Guay C, Roggli E, Nesca V, et al. (2011) Diabetes mellitus, a microRNA-related disease? Trans Res 157, 253-264.
64. Lynn FC (2009) Meta-regulation: microRNA regulation of glucose and lipid metabolism. Trends Endocrinol Metab 20, 452-459.
65. Chen H, Lan HY, Roukos DH, et al. (2014) Application of microRNAs in diabetes mellitus. J Endocrinol 222, R1-R10.
66. Dweep H & Gretz N (2015) miRWalk2. 0: a comprehensive atlas of microRNA-target interactions. Nat Methods 12, 697.
67. Collares CV, Evangelista AF, Xavier DJ, et al. (2013) Identifying common and specific microRNAs expressed in peripheral blood mononuclear cell of type 1, type 2, and gestational diabetes mellitus patients. BMC Res Notes 6, 491.
68. Fu G, Brkic J, Hayder H, et al. (2013) MicroRNAs in human placental development and pregnancy complications. Int J Mol Sci 14, 5519-5544.
69. Zhao C, Dong J, Jiang T, et al. (2011) Early second-trimester serum miRNA profiling predicts gestational diabetes mellitus. PLoS ONE 6, e23925.
70. Zhu Y, Tian F, Li H, et al. (2015) Profiling maternal plasma microRNA expression in early pregnancy to predict gestational diabetes mellitus. Int J Gynaecol Obstet 130, 49-53.
71. Etheridge A, Lee I, Hood L, et al. (2011) Extracellular microRNA: a new source of biomarkers. Mutat Res 717, 85-90.
72. He A, Zhu L, Gupta N, et al. (2007) Overexpression of micro ribonucleic acid 29, highly up-regulated in diabetic rats, leads to insulin resistance in 3T3-L1 adipocytes. Mol Endocrinol 21, 2785-2794.
73. Yang WM, Jeong HJ, Park SY, et al. (2014) Induction of miR-29a by saturated fatty acids impairs insulin signaling and glucose uptake through translational repression of IRS-1 in myocytes. FEBS Lett 588, 2170-2176.
74. Bagge A, Clausen TR, Larsen S, et al. (2012) MicroRNA-29a is up-regulated in beta-cells by glucose and decreases glucosestimulated insulin secretion. Biochem Biophys Res Commun 426, 266-272.
75. Nesca V, Guay C, Jacovetti C, et al. (2013) Identification of particular groups of microRNAs that positively or negatively impact on beta cell function in obese models of type 2 diabetes. Diabetologia 56, 2203-2212.
76. Shi Z, Zhao C, Guo X, et al. (2014) Differential expression of microRNAs in omental adipose tissue from gestational diabetes mellitus subjects reveals miR-222 as a regulator of ERalpha expression in estrogen-induced insulin resistance. Endocrinology 155, 1982-1990.
77. Zhou B, Li C, Qi W, et al. (2012) Downregulation of miR-181a upregulates sirtuin-1 (SIRT1) and improves hepatic insulin sensitivity. Diabetologia 55, 2032-2043.
78. Arola-Arnal A & Blade C (2011) Proanthocyanidins modulate microRNA expression in human HepG2 cells. PLoS ONE 6, e25982.
79. Bridge G, Monteiro R, Henderson S, et al. (2012) The microRNA-30 family targets DLL4 to modulate endothelial cell behavior during angiogenesis. Blood 120, 5063-5072.
80. Pietro L, Daher S, Rudge MV, et al. (2010) Vascular endothelial growth factor (VEGF) and VEGF-receptor expression in placenta of hyperglycemic pregnant women. Placenta 31, 770-780.
81. Joglekar MV, Patil D, Joglekar VM, et al. (2009) The miR-30 family microRNAs confer epithelial phenotype to human pancreatic cells. Islets 1, 137-147.
82. Zhang C, Tobias DK, Chavarro JE, et al. (2014) Adherence to healthy lifestyle and risk of gestational diabetes mellitus: prospective cohort study. BMJ 349, g5450.
83. Hanhineva K, Torronen R, Bondia-Pons I, et al. (2010) Impact of dietary polyphenols on carbohydrate metabolism. Int J Mol Sci 11, 1365-1402.
84. Berna G, Oliveras-Lopez MJ, Jurado-Ruiz E, et al. (2014) Nutrigenetics and nutrigenomics insights into diabetes etiopathogenesis. Nutrients 6, 5338-5369.
85. Babu PV, Liu D & Gilbert ER (2013) Recent advances in understanding the anti-diabetic actions of dietary flavonoids. J Nutr Biochem 24, 1777-1789.
86. Garcia-Segura L, Perez-Andrade M & Miranda-Rios J (2013) The emerging role of microRNAs in the regulation of gene expression by nutrients. J Nutrigenet Nutrigenomics 6, 16-31.
87. Palmer JD, Soule BP, Simone BA, et al. (2014) MicroRNA expression altered by diet: can food be medicinal? Ageing Res Rev 17, 16-24.
88. Milenkovic D, Jude B & Morand C (2013) miRNA as molecular target of polyphenols underlying their biological effects. Free Radi Biol Med 64, 40-51.
89. Jimenez M, Dorado L, Hernandez-Perez M, et al. (2014) Ankle-brachial index in screening for asymptomatic carotid and intracranial atherosclerosis. Atherosclerosis 233, 72-75.
90. Crozier A, Jaganath IB & Clifford MN (2009) Dietary phenolics: chemistry, bioavailability and effects on health. Nat Prod Rep 26, 1001-1043.
91. Fu Z & Liu D (2009) Long-term exposure to genistein improves insulin secretory function of pancreatic beta-cells. Eur J Pharmacol 616, 321-327.
92. Cai EP & Lin JK (2009) Epigallocatechin gallate (EGCG) and rutin suppress the glucotoxicity through activating IRS2 and AMPK signaling in rat pancreatic beta cells. J Agri Food Chem 57, 9817-9827.
93. Yu LF, Qiu BY, Nan FJ, et al. (2010) AMPK activators as novel therapeutics for type 2 diabetes. Curr Top Med Chem 10, 397-410.
94. Zhang ZF, Li Q, Liang J, et al. (2010) Epigallocatechin-3-Ogallate (EGCG) protects the insulin sensitivity in rat L6 muscle cells exposed to dexamethasone condition. Phytomedicine 17, 14-18.
95. Tsang WP & Kwok TT (2010) Epigallocatechin gallate up-regulation of miR-16 and induction of apoptosis in human cancer cells. J Nutr Biochem 21, 140-146.
96. Takikawa M, Inoue S, Horio F, et al. (2010) Dietary anthocyanin-rich bilberry extract ameliorates hyperglycemia and insulin sensitivity via activation of AMP-activated protein kinase in diabetic mice. J Nutr 140, 527-533.
97. Sun CD, Zhang B, Zhang JK, et al. (2012) Cyanidin-3-glucoside-rich extract from Chinese bayberry fruit protects pancreatic beta cells and ameliorates hyperglycemia in streptozotocin-induced diabetic mice. J Med Food 15, 288-298.
98. Scazzocchio B, Vari R, Filesi C, et al. (2011) Cyanidin-3-Obeta-glucoside and protocatechuic acid exert insulin-like effects by upregulating PPARgamma activity in human omental adipocytes. Diabetes 60, 2234-2244.
99. Masella R, Santangelo C, D'Archivio M, et al. (2012) Protocatechuic acid and human disease prevention: biological activities and molecular mechanisms. Curr Med Chem 19, 2901-2917.
100. Scazzocchio B, Vari R, Filesi C, et al. (2015) Protocatechuic acid activates key components of insulin signaling pathway mimicking insulin activity. Mol Nutr Food Res 59, 1472-1481.
101. Bhattacharya S, Oksbjerg N, Young JF, et al. (2014) Caffeic acid, naringenin and quercetin enhance glucose-stimulated insulin secretion and glucose sensitivity in INS-1E cells. Diabetes Obes Metab 16, 602-612.
102. Song Z, Wang H, Zhu L, et al. (2015) Curcumin improves high glucose-induced INS-1 cell insulin resistance via activation of insulin signaling. Food Funct 6, 461-469.
103. Zhang J, Du Y, Wu C, et al. (2010) Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186 signaling pathway. Oncol Rep 24, 1217-1223.
104. Sun M, Estrov Z, Ji Y, et al. (2008) Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol Cancer Ther 7, 464-473.
105. Choi MS, Jung UJ, Yeo J, et al. (2008) Genistein and daidzein prevent diabetes onset by elevating insulin level and altering hepatic gluconeogenic and lipogenic enzyme activities in non-obese diabetic (NOD) mice. Diabetes Metab Res Rev 24, 74-81.
106. Milenkovic D, Deval C, Gouranton E, et al. (2012) Modulation of miRNA expression by dietary polyphenols in apoE deficient mice: a new mechanism of the action of polyphenols. PLOS ONE 7, e29837.
107. Stull AJ, Cash KC, Johnson WD, et al. (2010) Bioactives in blueberries improve insulin sensitivity in obese, insulinresistant men and women. J Nutr 140, 1764-1768.
108. Wedick NM, Pan A, Cassidy A, et al. (2012) Dietary flavonoid intakes and risk of type 2 diabetes in US men and women. Am J Clin Nutr 95, 925-933.
109. Lappas M (2014) Effect of pre-existing maternal obesity, gestational diabetes and adipokines on the expression of genes involved in lipid metabolism in adipose tissue. Metabolism 63, 250-262.
110. D'Ippolito S, Tersigni C, Scambia G, et al. (2012) Adipokines, an adipose tissue and placental product with biological functions during pregnancy. Biofactors 38, 14-23.
111. Hauguel-de Mouzon S & Guerre-Millo M (2006) The placenta cytokine network and inflammatory signals. Placenta 27, 794-798.
112. Friis CM, Paasche Roland MC, Godang K, et al. (2013) Adiposity-related inflammation: effects of pregnancy. Obesity 21, E124-E130.
113. Barbour LA, McCurdy CE, Hernandez TL, et al. (2007) Cellular mechanisms for insulin resistance in normal pregnancy and gestational diabetes. Diabetes Care 30, Suppl. 2, S112-S119.
114. Li HP, Chen X & Li MQ (2013) Gestational diabetes induces chronic hypoxia stress and excessive inflammatory response in murine placenta. Int J Clin Exp Pathol 6, 650-659.
115. Xu Y, Jin B, Sun L, et al. (2014) The expression of FoxO1 in placenta and omental adipose tissue of gestational diabetes mellitus. Exp Clin Endocrinol Diabetes 122, 287-294.
116. Miehle K, Stepan H & Fasshauer M (2012) Leptin, adiponectin and other adipokines in gestational diabetes mellitus and pre-eclampsia. Clin Endocrinol 76, 2-11.
117. Retnakaran R, Hanley AJ, Raif N, et al. (2004) Reduced adiponectin concentration in women with gestational diabetes: a potential factor in progression to type 2 diabetes. Diabetes Care 27, 799-800.
118. Rasouli N & Kern PA (2008) Adipocytokines and the metabolic complications of obesity. J Clin Endocrinol Metab 93, S64-S73.
119. Lacroix M, Battista MC, Doyon M, et al. (2013) Lower adiponectin levels at first trimester of pregnancy are associated with increased insulin resistance and higher risk of developing gestational diabetes mellitus. Diabetes Care 36, 1577-1583.
120. Hedderson MM, Darbinian J, Havel PJ, et al. (2013) Low prepregnancy adiponectin concentrations are associated with a marked increase in risk for development of gestational diabetes mellitus. Diabetes Care 36, 3930-3937.
121. Yamauchi T, Kamon J, Minokoshi Y, et al. (2002) Adiponectin stimulates glucose utilization and fatty-acid oxidation by activating AMP-activated protein kinase. Nat Med 8, 1288-1295.
122. Visiedo F, Bugatto F, Sanchez V, et al. (2013) High glucose levels reduce fatty acid oxidation and increase triglyceride accumulation in human placenta. Am J Physiol Endocrinol Metab 305, E205-E212.
123. Astapova O & Leff T (2012) Adiponectin and PPARgamma: cooperative and interdependent actions of two key regulators of metabolism. Vitam Horm 90, 143-162.
124. Berg AH & Scherer PE (2005) Adipose tissue, inflammation, and cardiovascular disease. Circ Res 96, 939-949.
125. Aye IL, Rosario FJ, Powell TL, et al. (2015) Adiponectin supplementation in pregnant mice prevents the adverse effects of maternal obesity on placental function and fetal growth. Proc Natl Acad Sci U S A 112, 12858-12863.
126. Li FY, Cheng KK, Lam KS, et al. (2011) Cross-talk between adipose tissue and vasculature: role of adiponectin. Acta Physiol (Oxf) 203, 167-180.
127. Lepercq J, Cauzac M, Lahlou N, et al. (1998) Overexpression of placental leptin in diabetic pregnancy: a critical role for insulin. Diabetes 47, 847-850.
128. Lappas M (2014) Markers of endothelial cell dysfunction are increased in human omental adipose tissue from women with pre-existing maternal obesity and gestational diabetes. Metabolism 63, 860-873.
129. Qiu C, Williams MA, Vadachkoria S, et al. (2004) Increased maternal plasma leptin in early pregnancy and risk of gestational diabetes mellitus. Obstet Gynecol 103, 519-525.
130. Al-Badri MR, Zantout MS & Azar ST (2015) The role of adipokines in gestational diabetes mellitus. Ther Adv Endocrinol Metab 6, 103-108.
131. Saucedo R, Zarate A, Basurto L, et al. (2011) Relationship between circulating adipokines and insulin resistance during pregnancy and postpartum in women with gestational diabetes. Arch Med Res 42, 318-323.
132. Bao W, Baecker A, Song Y, et al. (2015) Adipokine levels during the first or early second trimester of pregnancy and subsequent risk of gestational diabetes mellitus: a systematic review. Metabolism 64, 756-764.
133. Xu J, Zhao YH, Chen YP, et al. (2014) Maternal circulating concentrations of tumor necrosis factor-alpha, leptin, and adiponectin in gestational diabetes mellitus: a systematic review and meta-analysis. ScientificWorldJournal 2014, 926932.
134. Hegyi K, Fulop K, Kovacs K, et al. (2004) Leptin-induced signal transduction pathways. Cell Biol Int 28, 159-169.
135. Santos-Alvarez J, Goberna R & Sanchez-Margalet V (1999) Human leptin stimulates proliferation and activation of human circulating monocytes. Cell Immunol 194, 6-11.
136. Wojcik M, Chmielewska-Kassassir M, Grzywnowicz K, et al. (2014) The relationship between adipose tissue-derived hormones and gestational diabetes mellitus (GDM). Endokrynol Pol 65, 134-142.
137. Li YY, Xiao R, Li CP, et al. (2015) Increased plasma levels of FABP4 and PTEN is associated with more severe insulin resistance in women with gestational diabetes mellitus. Med Sci Monit 21, 426-431.
138. Landberg R, Naidoo N & van Dam RM (2012) Diet and endothelial function: from individual components to dietary patterns. Curr Opin Lipidol 23, 147-155.
139. Favero G, Paganelli C, Buffoli B, et al. (2014) Endothelium and its alterations in cardiovascular diseases: life style intervention. Biomed Res Int 2014, 801896.
140. Schwingshackl L & Hoffmann G (2014) Mediterranean dietary pattern, inflammation and endothelial function: a systematic review and meta-analysis of intervention trials. Nutr Metab Cardiovasc Dis 24, 929-939.
141. Caselli C (2014) Role of adiponectin system in insulin resistance. Mol Genet Metab 113, 155-160.
142. Wang A, Liu M, Liu X, et al. (2011) Up-regulation of adiponectin by resveratrol: the essential roles of the Akt/FOXO1 and AMP-activated protein kinase signaling pathways and DsbA-L. J Biol Chem 286, 60-66.
143. Eseberri I, Lasa A, Churruca I, et al. (2013) Resveratrol metabolites modify adipokine expression and secretion in 3T3-L1 pre-adipocytes and mature adipocytes. PLOS ONE 8, e63918.
144. Kang L, Heng W, Yuan A, et al. (2010) Resveratrol modulates adipokine expression and improves insulin sensitivity in adipocytes: relative to inhibition of inflammatory responses. Biochimie 92, 789-796.
145. Peng XL, Qu W, Wang LZ, et al. (2014) Resveratrol ameliorates high glucose and high-fat/sucrose diet-induced vascular hyperpermeability involving Cav-1/eNOS regulation. PLOS ONE 9, e113716.
146. Liu Y, Li D, Zhang Y, et al. (2014) Anthocyanin increases adiponectin secretion and protects against diabetes-related endothelial dysfunction. Am J Physiol Endocrinol Metab 306, E975-E988.
147. Jin T, Kim OY, Shin MJ, et al. (2014) Fisetin up-regulates the expression of adiponectin in 3T3-L1 adipocytes via the activation of silent mating type information regulation 2 homologue 1 (SIRT1)-deacetylase and peroxisome proliferator-activated receptors (PPARs). J Agri Food Chem 62, 10468-10474.
148. Khan N, Syed DN, Ahmad N, et al. (2013) Fisetin: a dietary antioxidant for health promotion. Antioxid Redox Signal 19, 151-162.
149. Scoditti E, Massaro M, Carluccio MA, et al. (2015) Additive regulation of adiponectin expression by the Mediterranean diet olive oil components oleic acid and hydroxytyrosol in human adipocytes. PLOS ONE 10, e0128218.
150. Lamy S, Ouanouki A, Beliveau R, et al. (2014) Olive oil compounds inhibit vascular endothelial growth factor receptor-2 phosphorylation. Exp Cell Res 322, 89-98.
151. Niwa T, Yokoyama S, Ito T, et al. (2010) Reduction of leptin secretion by soy isoflavonoids in murine adipocytes in vitro. Phytochem Lett 3, 122-125.
152. Yanagisawa M, Sugiya M, Iijima H, et al. (2012) Genistein and daidzein, typical soy isoflavones, inhibit TNF-alphamediated downregulation of adiponectin expression via different mechanisms in 3T3-L1 adipocytes. Mol Nutr Food Res 56, 1783-1793.
153. Chen J, Mo H, Guo R, et al. (2014) Inhibition of the leptin-induced activation of the p38 MAPK pathway contributes to the protective effects of naringin against high glucose-induced injury in H9c2 cardiac cells. Int J Mol Med 33, 605-612.
154. Mahmoud AM, Ashour MB, Abdel-Moneim A, et al. (2012) Hesperidin and naringin attenuate hyperglycemia-mediated oxidative stress and proinflammatory cytokine production in high fat fed/streptozotocin-induced type 2 diabetic rats. J Diabetes Complications 26, 483-490.
155. Sakane N, Kotani K, Tsuzaki K, et al. (2014) Equol producers can have low leptin levels among prediabetic and diabetic females. Ann Endocrinol (Paris) 75, 25-28.
156. Llaneza P, Gonzalez C, Fernandez-Inarrea J, et al. (2011) Soy isoflavones, diet and physical exercise modify serum cytokines in healthy obese postmenopausal women. Phytomedicine 18, 245-250.
157. Gupta SC, Tyagi AK, Deshmukh-Taskar P, et al. (2014) Downregulation of tumor necrosis factor and other proinflammatory biomarkers by polyphenols. Arch Biochem Biophys 559, 91-99.
158. Rebholz SL, Burke KT, Yang Q, et al. (2011) Dietary fat impacts fetal growth and metabolism: uptake of chylomicron remnant core lipids by the placenta. Am J Physiol Endocrinol Metab 301, E416-E425.
159. Jones ML, Mark PJ & Waddell BJ (2014) Maternal dietary omega-3 fatty acids and placental function. Reproduction 147, R143-R152.
160. Herrera E & Ortega-Senovilla H (2010) Disturbances in lipid metabolism in diabetic pregnancy-are these the cause of the problem? Best Pract Res Clin Endocrinol Metab 24, 515-525.
161. Haggarty P (2010) Fatty acid supply to the human fetus. Ann Rev Nutr 30, 237-255.
162. Gil-Sanchez A, Demmelmair H, Parrilla JJ, et al. (2011) Mechanisms involved in the selective transfer of long chain polyunsaturated fatty acids to the fetus. Front Genet 2, 57.
163. Pagan A, Prieto-Sanchez MT, Blanco-Carnero JE, et al. (2013) Materno-fetal transfer of docosahexaenoic acid is impaired by gestational diabetes mellitus. Am J Physiol Endocrinol Metab 305, E826-E833.
164. Araujo JR, Correia-Branco A, Ramalho C, et al. (2013) Gestational diabetes mellitus decreases placental uptake of long-chain polyunsaturated fatty acids: involvement of longchain acyl-CoA synthetase. J Nutr Biochem 24, 1741-1750.
165. Gauster M, Hiden U, van Poppel M, et al. (2011) Dysregulation of placental endothelial lipase in obese women with gestational diabetes mellitus. Diabetes 60, 2457-2464.
166. Barrett HL, Kubala MH, Scholz Romero K, et al. (2014) Placental lipases in pregnancies complicated by gestational diabetes mellitus (GDM). PLOS ONE 9, e104826.
167. Duttaroy AK (2009) Transport of fatty acids across the human placenta: a review. Prog Lipid Res 48, 52-61.
168. Jawerbaum A & Capobianco E (2011) Review: effects of PPAR activation in the placenta and the fetus: implications in maternal diabetes. Placenta 32, Suppl. 2, S212-S217.
169. Simopoulos AP (2011) Evolutionary aspects of diet: the omega-6/omega-3 ratio and the brain. Mol Neurobiol 44, 203-215.
170. Calder PC (2012) Mechanisms of action of (n-3) fatty acids. J Nutr 142, 592S-599S.
171. Russo GL (2009) Dietary n-6 and n-3 polyunsaturated fatty acids: from biochemistry to clinical implications in cardiovascular prevention. Biochem Pharmacol 77, 937-946.
172. Zinati Z, Zamansani F, Hossein KayvanJoo A, et al. (2014) New layers in understanding and predicting alpha-linolenic acid content in plants using amino acid characteristics of omega-3 fatty acid desaturase. Comput Biol Med 54, 14-23.
173. Burns-Whitmore B, Haddad E, Sabate J, et al. (2014) Effects of supplementing n-3 fatty acid enriched eggs and walnuts on cardiovascular disease risk markers in healthy free-living lacto-ovo-vegetarians: a randomized, crossover, free-living intervention study. Nutr J 13, 29.
174. Mayneris-Perxachs J, Sala-Vila A, Chisaguano M, et al. (2014) Effects of 1-year intervention with a Mediterranean diet on plasma fatty acid composition and metabolic syndrome in a population at high cardiovascular risk. PLOS ONE 9, e85202.
175. Galli C & Marangoni F (2006) N-3 fatty acids in the Mediterranean diet. Prostaglandins Leukot Essent Fatty Acids 75, 129-133.
176. Uddin MK, Juraimi AS, Hossain MS, et al. (2014) Purslane weed (Portulaca oleracea): a prospective plant source of nutrition, omega-3 fatty acid, and antioxidant attributes. ScientificWorldJournal 2014, 951019.
177. Panagiotakos D, Kalogeropoulos N, Pitsavos C, et al. (2009) Validation of the MedDietScore via the determination of plasma fatty acids. Int J Food Sci Nutr 60, Suppl. 5, 168-180.
178. Feart C, Torres MJ, Samieri C, et al. (2011) Adherence to a Mediterranean diet and plasma fatty acids: data from the Bordeaux sample of the Three-City study. Br J Nutr 106, 149-158.
179. Ambring A, Johansson M, Axelsen M, et al. (2006) Mediterranean-inspired diet lowers the ratio of serum phospholipid n-6 to n-3 fatty acids, the number of leukocytes and platelets, and vascular endothelial growth factor in healthy subjects. Am J Clin Nutr 83, 575-581.
180. Scoditti E, Capurso C, Capurso A, et al. (2014) Vascular effects of the Mediterranean diet-part II: role of omega-3 fatty acids and olive oil polyphenols. Vascul Pharmacol 63, 127-134.
181. Koletzko B, Lien E, Agostoni C, et al. (2008) The roles of long-chain polyunsaturated fatty acids in pregnancy, lactation and infancy: review of current knowledge and consensus recommendations. J Perinat Med 36, 5-14.
182. Pietrantoni E, Del Chierico F, Rigon G, et al. (2014) Docosahexaenoic acid supplementation during pregnancy: a potential tool to prevent membrane rupture and preterm labor. Int J Mol Sci 15, 8024-8036.
183. Carvajal JA (2014) Docosahexaenoic acid supplementation early in pregnancy may prevent deep placentation disorders. Biomed Res Int 2014, 526895.
184. Mohammadi E, Rafraf M, Farzadi L, et al. (2012) Effects of omega-3 fatty acids supplementation on serum adiponectin levels and some metabolic risk factors in women with polycystic ovary syndrome. Asia Pac J Clin Nutr 21, 511-518.
185. Lu J, Borthwick F, Hassanali Z, et al. (2011) Chronic dietary n-3 PUFA intervention improves dyslipidaemia and subsequent cardiovascular complications in the JCR:LA-cp rat model of the metabolic syndrome. Br J Nutr 105, 1572-1582.
186. Min Y, Djahanbakhch O, Hutchinson J, et al. (2014) Effect of docosahexaenoic acid-enriched fish oil supplementation in pregnant women with type 2 diabetes on membrane fatty acids and fetal body composition-double-blinded randomized placebo-controlled trial. Diabet Med 31, 1331-1340.
187. Recchiuti A & Serhan CN (2012) Pro-resolving lipid mediators (SPMs) and their actions in regulating miRNA in novel resolution circuits in inflammation. Front Immunol 3, 298.
188. Jones ML, Mark PJ, Keelan JA, et al. (2013) Maternal dietary omega-3 fatty acid intake increases resolvin and protectin levels in the rat placenta. J Lipid Res 54, 2247-2254.
189. Keelan JA, Mas E, D'Vaz N, et al. (2015) Effects of maternal n-3 fatty acid supplementation on placental cytokines, pro-resolving lipid mediators and their precursors. Reproduction 149, 171-178.
190. Jamilian M, Samimi M, Kolahdooz F, et al. (2016) Omega-3 fatty acid supplementation affects pregnancy outcomes in gestational diabetes: a randomized, double-blind, placebocontrolled trial. J Matern Fetal Neonatal Med 29, 669-675.
191. Jia X, Pakseresht M, Wattar N, et al. (2015) Women who take n-3 long-chain polyunsaturated fatty acid supplements during pregnancy and lactation meet the recommended intake. App Physiol Nutr Metab 40, 474-481.
192. Higuchi T, Shirai N, Saito M, et al. (2008) Levels of plasma insulin, leptin and adiponectin, and activities of key enzymes in carbohydrate metabolism in skeletal muscle and liver in fasted ICR mice fed dietary n-3 polyunsaturated fatty acids. J Nutr Biochem 19, 577-586.
193. O'Tierney-Ginn P, Roberts V, Gillingham M, et al. (2015) Influence of high fat diet and resveratrol supplementation on placental fatty acid uptake in the Japanese macaque. Placenta 36, 903-910.
194. Bellenger J, Bellenger S, Bataille A, et al. (2011) High pancreatic n-3 fatty acids prevent STZ-induced diabetes in fat-1 mice: inflammatory pathway inhibition. Diabetes 60, 1090-1099.
195. Oh DY, Talukdar S, Bae EJ, et al. (2010) GPR120 is an omega-3 fatty acid receptor mediating potent anti-inflammatory and insulin-sensitizing effects. Cell 142, 687-698.
196. Li K, Huang T, Zheng J, et al. (2014) Effect of marine-derived n-3 polyunsaturated fatty acids on C-reactive protein, interleukin 6 and tumor necrosis factor alpha: a meta-analysis. PLOS ONE 9, e88103.
197. Harris WS (2014) Achieving optimal n-3 fatty acid status: the vegetarian's challenge. or not. Am J Clin Nutr 100, Suppl. 1, 449S-452S.
198. Rajaram S (2014) Health benefits of plant-derived alphalinolenic acid. Am J Clin Nutr 100, Suppl. 1, 443S-448S.
199. Adarme-Vega TC, Lim DK, Timmins M, et al. (2012) Microalgal biofactories: a promising approach towards sustainable omega-3 fatty acid production. Microb Cell Fact 11, 96.
200. Lenihan-Geels G, Bishop KS & Ferguson LR (2013) Alternative sources of omega-3 fats: can we find a sustainable substitute for fish? Nutrients 5, 1301-1315.